Literature DB >> 21888831

Unfolded protein response suppresses cisplatin-induced apoptosis via autophagy regulation in human hepatocellular carcinoma cells.

R Chen1, R Y Dai, C Y Duan, Y P Liu, S K Chen, D M Yan, C N Chen, M Wei, H Li.   

Abstract

It has been shown that drug resistance is extremely common in hepatocellular carcinoma (HCC) and is one of the major problems in HCC chemotherapy. However, the detailed mechanisms remain largely unknown. We have previously shown that endoplasmic reticulum (ER) stress is involved in the tumorigenesis of HCC. Here, we demonstrated that the unfolded protein response (UPR) inhibits cisplatin-induced HCC cell apoptosis. In HCC cells, cisplatin treatment triggers the UPR, which subsequently inhibits cisplatin-induced apoptosis. Importantly, mild ER stress precondition suppresses the sensitivity of HCC cells to cisplatin-induced apoptosis through autophagy regulation. Furthermore, heat-shock protein 27 (Hsp27) is involved in the cytoprotective role of the UPR in cisplatin-induced apoptosis. We also demonstrated that Hsp27 inhibits cisplatin- induced HCC cell death through autophagy activation. Taken together, our results indicate that the UPR inhibits cisplatin-induced apoptosis in HCC cells, at least in part, by Hsp27-mediated autophagy activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21888831

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  19 in total

1.  Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F.

Authors:  Nicholas U Schwartz; Ryan W Linzer; Jean-Philip Truman; Mikhail Gurevich; Yusuf A Hannun; Can E Senkal; Lina M Obeid
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

2.  Inhibition of beclin1 affects the chemotherapeutic sensitivity of osteosarcoma.

Authors:  Wenxin Wu; Wei Li; Yong Zhou; Chaoyue Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Molecular markers of DNA damage and repair in cervical cancer patients treated with cisplatin neoadjuvant chemotherapy: an exploratory study.

Authors:  Nilda E Real; Gisela N Castro; F Darío Cuello-Carrión; Claudia Perinetti; Hanna Röhrich; Niubys Cayado-Gutiérrez; Martin E Guerrero-Gimenez; Daniel R Ciocca
Journal:  Cell Stress Chaperones       Date:  2017-06-12       Impact factor: 3.667

4.  Role of endoplasmic reticulum stress on cisplatin resistance in ovarian carcinoma.

Authors:  Jing Tian; Rong Liu; Quanxin Qu
Journal:  Oncol Lett       Date:  2017-01-10       Impact factor: 2.967

5.  Activation of unfolded protein response protects osteosarcoma cells from cisplatin-induced apoptosis through NF-κB pathway.

Authors:  Mingming Yan; Jiangdong Ni; Deye Song; Muliang Ding; Jun Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 6.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

Review 7.  The unfolded protein response in fatty liver disease.

Authors:  Anne Henkel; Richard M Green
Journal:  Semin Liver Dis       Date:  2013-11-12       Impact factor: 6.115

Review 8.  A new strategy of promoting cisplatin chemotherapeutic efficiency by targeting endoplasmic reticulum stress.

Authors:  Ye Xu; Chunyan Wang; Zhixin Li
Journal:  Mol Clin Oncol       Date:  2013-10-18

9.  Small Heat Shock Protein Beta-1 (HSPB1) Is Upregulated and Regulates Autophagy and Apoptosis of Renal Tubular Cells in Acute Kidney Injury.

Authors:  Tatsuki Matsumoto; Madoka Urushido; Haruna Ide; Masayuki Ishihara; Kazu Hamada-Ode; Yoshiko Shimamura; Koji Ogata; Kosuke Inoue; Yoshinori Taniguchi; Takafumi Taguchi; Taro Horino; Shimpei Fujimoto; Yoshio Terada
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

10.  HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins.

Authors:  André-Patrick Arrigo; Benjamin Gibert
Journal:  Cancers (Basel)       Date:  2014-02-07       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.